Prognostic Value of Microvessel Density in Tumor and Peritumoral Area as Evaluated by CD31 Protein Expression and Argyrophilic Nucleolar Organizer Region Count in Endothelial Cells in Uterine Leiomyosarcoma
Figure 7
Cumulative proportion of 10-year survival of LMS patients, depending on the MVD in the PA (a) and the MVD in the tumor (b).
